A carregar...
Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
SIMPLE SUMMARY: The most successful strategies for solid cancer immunotherapy have centered on targeting the co-stimulatory and co-inhibitory T cell molecules that regulate T cell activation. Although immunotherapy that targets surface receptors such as CTLA-4 and/or PD-1 with recombinant antibodies...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8197903/ https://ncbi.nlm.nih.gov/pubmed/34073258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112600 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|